Replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line

Gene Therapy

Volumn 3, Issue 7, 1996, Pages 624-629

  Chong, H ^a   Vile, R G ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Helper virus; Packaging cell line; Replication competent retrovirus

Indexed keywords

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA PACKAGING; ENVELOPE GENE; GENE THERAPY; HELPER VIRUS; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RETROVIRUS; STRUCTURAL GENE; VIRUS REPLICATION;

3T3 CELLS; ANIMALS; CELL LINE; FUSION PROTEINS, GAG-POL; GENES, ENV; HUMANS; MICE; RETROVIRIDAE; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0029737735     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Miller A. Retroviral vectors. Curr Top in Microbiol Immunol 1992; 158: 1-24.
2. Vile RG, Russell SJ. Retroviruses as vectors, Br Med Bull 1995; 51: 12-30.
3. Miller AD. Retrovirus packaging cells. Hum Gene Ther 1990; 1: 5-14.
4. Cornetta K. Safety aspects of gene therapy. Br J Haematol 1992; 80: 421-426.
5. Cornetta K, Morgan RA, Anderson WF. Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther 1991; 2: 5-14.
6. Moolten FL, Cupples LA. A model for predicting the risk of cancer consequent to retroviral gene therapy. Hum Gene Ther 1992; 3: 479-486.
7. Donahue RE et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992; 176: 1125-1135.
8. Cone RD, Mulligan RC. High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci USA 1984; 81: 6349-6353.
9. Mann R, Mulligan RC, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33: 153-159.
10. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986; 6: 2895-2902.
11. Scarpa M et al. Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines. Virology 1991; 180: 849-852.
12. Otto E et al. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum Gene Ther 1994; 5: 567-575.
13. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
14. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988; 167: 400-406.
15. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988; 85: 6460-6464.
16. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587-3596.
17. Takeuchi Y et al. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 1994; 68: 8001-8007.
18. Takahara Y, Hamada K, Housman DE. A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes. J Virol 1992; 66: 3725-3732.
19. Sommerfelt MA, Weiss RA. Receptor interference groups of 20 retroviruses plating on human cells. Virology 1990; 176: 58-69.
20. Gunter KC, Khan AS, Noguchi PD. The safety of retroviral vectors. Hum Gene Ther 1993; 4: 643-645.
21. Anderson WF, McGarrity GJ, Moen RC. Report to the NIH recombinant DNA advisory committee on murine replication-competent retrovirus (RCR) assays. Hum Gene Ther 1993; 4: 311-321
22. Cosset F-L et al. High-titre packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
23. Vile RG, Hart IR. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 1993; 53: 962-967.